CN Patent

CN117599041B — 去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途

Assigned to Academy of Military Medical Sciences AMMS of PLA · Expires 2024-05-03 · 2y expired

What this patent protects

本发明公开了去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途，本发明首次发现去氢雌马酚在抗辐射损伤和抗化疗药物损伤方面的新用途，并通过实验进行证实，本发明为制备用于预防和/或治疗各种辐射损伤的药物提供了新的思路，并为制备用于预防和/或治疗各种化疗药物损伤的药物提供了新的策略，具有良好的临床应用前景。

USPTO Abstract

本发明公开了去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途，本发明首次发现去氢雌马酚在抗辐射损伤和抗化疗药物损伤方面的新用途，并通过实验进行证实，本发明为制备用于预防和/或治疗各种辐射损伤的药物提供了新的思路，并为制备用于预防和/或治疗各种化疗药物损伤的药物提供了新的策略，具有良好的临床应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN117599041B
Jurisdiction
CN
Classification
—
Expires
2024-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Academy of Military Medical Sciences AMMS of PLA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.